Odyssey Health (ODYY) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -8,475.58% |
| Oct 31, 2025 | 52.50% |
| Jul 31, 2025 | -702.19% |
| Apr 30, 2025 | 95.17% |
| Jan 31, 2025 | 95.67% |
| Oct 31, 2024 | 72.78% |
| Jul 31, 2024 | 93.55% |
| Apr 30, 2024 | -5,249.59% |
| Jan 31, 2024 | -364.18% |
| Oct 31, 2023 | -291.85% |
| Jul 31, 2023 | 49.18% |
| Apr 30, 2023 | 99.54% |
| Jan 31, 2023 | 72.75% |
| Oct 31, 2022 | 89.28% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 80.68% |
| Jan 31, 2022 | -108.23% |
| Oct 31, 2021 | -60.93% |
| Jul 31, 2021 | 86.97% |
| Apr 30, 2021 | -5,073.13% |
| Jan 31, 2021 | -2,186.05% |
| Oct 31, 2020 | -186.12% |
| Jul 31, 2020 | -233.09% |
| Apr 30, 2020 | -8,022.56% |
| Jan 31, 2020 | -338.63% |
| Oct 31, 2019 | -10,081.09% |
| Jul 31, 2019 | -42,744.87% |
| Apr 30, 2019 | 94.66% |
| Jan 31, 2019 | -56.08% |
| Oct 31, 2018 | 91.28% |
| Jul 31, 2018 | 97.10% |
| Apr 30, 2018 | -154.85% |
| Jan 31, 2018 | 94.99% |
| Oct 31, 2017 | -1,790.00% |
| Jul 31, 2017 | -515.59% |
| Apr 30, 2017 | 83.86% |
| Jan 31, 2017 | -417.57% |
| Oct 31, 2016 | 89.47% |
| Jul 31, 2016 | 59.23% |
| Apr 30, 2016 | -137.94% |
| Jan 31, 2016 | 95.67% |
| Oct 31, 2015 | 87.39% |
| Jul 31, 2015 | 97.91% |